阿肯色 的 轉移性癌症 臨床試驗
14 項針對 轉移性癌症 的研究正在 阿肯色 各地點尋找參與者。
阿肯色 的城市
官方研究文本（英文）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
招募中2 期
所有年齡 · 所有性別 · 更新於 2026年10月5日 · NCT05564377A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Arkansas Medical School, Little Rock
招募中1 期
19 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06586957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07222800A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Springdale
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06103864A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Central Arkansas Radiation Therapy Institute, dba CARTI, Bryant
- Central Arkansas Radiation Therapy Institute, dba CARTI, Conway
- CARTI Cancer Center, Little Rock
- 還有 2 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06989437Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07222566A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Arkansas for Medical Sciences, Little Rock
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Genesis Cancer and Blood Institute, Hot Springs
- Highlands Oncology Group, Springdale
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07174336Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, PA, Springdale
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月17日 · NCT07227415A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Highlands Oncology Group, Springdale
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月8日 · NCT06119581A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年7月30日 · NCT04657068Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Genesis Cancer and Blood Institute, Hot Springs
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年5月8日 · NCT06697301Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Mercy Hospital Fort Smith, Fort Smith
招募中觀察性研究
2 Months · 所有性別 · 更新於 2026年3月5日 · NCT02474160SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
招募中觀察性研究
所有年齡 · 所有性別 · 更新於 2025年10月28日 · NCT03452774資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。